MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Benya, R. V.
Right arrow Articles by Battey, J. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Benya, R. V.
Right arrow Articles by Battey, J. F.

Internalization of the gastrin-releasing peptide receptor is mediated by both phospholipase C-dependent and -independent processes

RV Benya, M Akeson, J Mrozinski, RT Jensen and JF Battey

Digestive Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892.

Consequent to agonist exposure, many G protein-coupled receptors undergo sequestration or internalization. Results with receptors linked to adenylate cyclase, such as the beta 2-adrenergic receptor, or receptors linked to phospholipase C (PLC) have provided conflicting results regarding the role of second messenger-dependent (i.e., protein kinase A or C) and -independent (i.e., beta-adrenergic receptor kinase) kinases in mediating this process. Recent results for truncated and mutated gastrin-releasing peptide (GRP) receptors (GRP-R), as well as muscarinic cholinergic receptors, suggest that activation of protein kinase C may be needed for full receptor internalization. Nearly all G protein-coupled receptors studied to date, including the GRP-R, possess two highly conserved amino acids that are important in mediating receptor-G protein coupling to second messengers, i.e., arginine in the proximal second intracellular loop and alanine in the distal third intracellular loop. We selectively mutated each of these residues in the GRP-R to determine their importance for activation of PLC. Site- directed mutagenesis was performed to change arginine at position 139 to glycine (R139G mutant) and alanine at position 263 to glutamate (A263E mutant), with stable cell lines being created by transfection of the wild-type or mutated receptor cDNA into BALB/3T3 fibroblasts. Both R139G (Kd = 12.0 +/- 1.6 nM) and A263E (Kd = 12.2 +/- 1.7 nM) had a lower affinity for bombesin than did wild-type GRP-R (Kd = 1.4 +/- 0.4 nM); however, characteristic stoichiometries for the binding of agonists to this receptor were maintained equally in all three cell lines (bombesin > GRP >> neuromedin B). The wild-type GRP-R exposed to bombesin increased [3H]inositol phosphates (a measure of PLC activation) approximately 4-fold, with an EC50 of 5.1 +/- 2.2 nM. In contrast, [3H]inositol phosphates were not significantly increased in cells expressing R139G or A263E receptors, demonstrating that Arg139 and Ala263 are required for GRP-R activation of PLC. However, when receptor internalization at 37 degrees was assessed by ligand acid- stripping studies, 53 +/- 2% of A263E receptors were internalized at 90 min, compared with 85 +/- 5% of wild-type GRP-R, whereas only 10 +/- 3% of R139G receptors were internalized. Preincubation of either mutant cell line with 100 nM 12-O-tetradecanoylphorbol-13-acetate markedly increased internalization rates, such that at 90 min 62 +/- 2% of R139G receptors and 82 +/- 1% of A263E receptors were internalized.(ABSTRACT TRUNCATED AT 400 WORDS)

Volume 46, Issue 3, pp. 495-501, 09/01/1994
Copyright © 1994 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
Pharmacol. Rev.Home page
R. T. Jensen, J. F. Battey, E. R. Spindel, and R. V. Benya
International Union of Pharmacology. LXVIII. Mammalian Bombesin Receptors: Nomenclature, Distribution, Pharmacology, Signaling, and Functions in Normal and Disease States
Pharmacol. Rev., March 1, 2008; 60(1): 1 - 42.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
N. Gonzalez, S. J. Hocart, S. Portal-Nunez, S. A. Mantey, T. Nakagawa, E. Zudaire, D. H. Coy, and R. T. Jensen
Molecular Basis for Agonist Selectivity and Activation of the Orphan Bombesin Receptor Subtype 3 Receptor
J. Pharmacol. Exp. Ther., February 1, 2008; 324(2): 463 - 474.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
P. Vazquez, I. Roncero, E. Blazquez, and E. Alvarez
The cytoplasmic domain close to the transmembrane region of the glucagon-like peptide-1 receptor contains sequence elements that regulate agonist-dependent internalisation
J. Endocrinol., July 1, 2005; 186(1): 221 - 231.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
P.-W. Chen and G. S. Kroog
Alterations in Receptor Expression or Agonist Concentration Change the Pathways Gastrin-Releasing Peptide Receptor Uses to Regulate Extracellular Signal-Regulated Kinase
Mol. Pharmacol., December 1, 2004; 66(6): 1625 - 1634.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. Schumann, T. Nakagawa, S. A. Mantey, K. Tokita, D. J. Venzon, S. J. Hocart, R. V. Benya, and R. T. Jensen
Importance of Amino Acids of the Central Portion of the Second Intracellular Loop of the Gastrin-Releasing Peptide Receptor for Phospholipase C Activation, Internalization, and Chronic Down-Regulation
J. Pharmacol. Exp. Ther., November 1, 2003; 307(2): 597 - 607.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
R. A. Ally, K. L. Ives, E. Traube, I. Eltounsi, P.-W. Chen, P. J. Cahill, J. F. Battey, M. R. Hellmich, and G. S. Kroog
Agonist- and Protein Kinase C-Induced Phosphorylation Have Similar Functional Consequences for Gastrin-Releasing Peptide Receptor Signaling via Gq
Mol. Pharmacol., October 1, 2003; 64(4): 890 - 904.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
Y. Lin, X. Jian, Z. Lin, G. S. Kroog, S. Mantey, R. T. Jensen, J. Battey, and J. Northup
Two Amino Acids in the Sixth Transmembrane Segment of the Mouse Gastrin-Releasing Peptide Receptor Are Important for Receptor Activation
J. Pharmacol. Exp. Ther., September 1, 2000; 294(3): 1053 - 1062.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
R. Yu and P. M. Hinkle
Signal Transduction and Hormone-dependent Internalization of the Thyrotropin-releasing Hormone Receptor in Cells Lacking Gq and G11
J. Biol. Chem., May 28, 1999; 274(22): 15745 - 15750.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X. Jian, E. Sainz, W. A. Clark, R. T. Jensen, J. F. Battey, and J. K. Northup
The Bombesin Receptor Subtypes Have Distinct G Protein Specificities
J. Biol. Chem., April 23, 1999; 274(17): 11573 - 11581.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
Z. Huang, T. Bambino, Y. Chen, J. Lameh, and R. A. Nissenson
Role of Signal Transduction in Internalization of the G Protein-Coupled Receptor for Parathyroid Hormone (PTH) and PTH-Related Protein
Endocrinology, March 1, 1999; 140(3): 1294 - 1300.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Cell Physiol.Home page
B. F. Roettger, D. I. Pinon, T. P. Burghardt, and L. J. Miller
Regulation of lateral mobility and cellular trafficking of the CCK receptor by a partial agonist
Am J Physiol Cell Physiol, March 1, 1999; 276(3): C539 - C547.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
B. Y. Williams, S. B. Dion, and A. Schonbrunn
Role of Receptor and Protein Kinase C Activation in the Internalization of the Gastrin-Releasing Peptide Receptor
Mol. Pharmacol., November 1, 1998; 54(5): 889 - 898.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
N. Hukovic, R. Panetta, U. Kumar, M. Rocheville, and Y. C. Patel
The Cytoplasmic Tail of the Human Somatostatin Receptor Type 5 Is Crucial for Interaction with Adenylyl Cyclase and in Mediating Desensitization and Internalization
J. Biol. Chem., August 14, 1998; 273(33): 21416 - 21422.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
P. G. Szekeres, J. A. Koenig, and J. M. Edwardson
The Relationship between Agonist Intrinsic Activity and the Rate of Endocytosis of Muscarinic Receptors in a Human Neuroblastoma Cell Line
Mol. Pharmacol., April 1, 1998; 53(4): 759 - 765.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
S. Conchon, N. Peltier, P. Corvol, and E. Clauser
A noninternalized nondesensitized truncated AT1A receptor transduces an amplified ANG II signal
Am J Physiol Endocrinol Metab, February 1, 1998; 274(2): E336 - E345.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. J. Mandell, K. A. Selz, and M. F. Shlesinger
Mode matches and their locations in the hydrophobic free energy sequences of peptide ligands and their receptor eigenfunctions
PNAS, December 9, 1997; 94(25): 13576 - 13581.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M.-J. Tseng, K. Detjen, V. Struk, and C. D. Logsdon
Carboxyl-terminal Domains Determine Internalization and Recycling Characteristics of Bombesin Receptor Chimeras
J. Biol. Chem., August 11, 1995; 270(32): 18858 - 18864.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M.-J. Tseng, S. Coon, E. Stuenkel, V. Struk, and C. D. Logsdon
Influence of Second and Third Cytoplasmic Loops on Binding, Internalization, and Coupling of Chimeric Bombesin/m3 Muscarinic Receptors
J. Biol. Chem., July 28, 1995; 270(30): 17884 - 17891.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. V. Benya, T. Kusui, J. F. Battey, and R. T. Jensen
Chronic Desensitization and Down-regulation of the Gastrin-releasing Peptide Receptor Are Mediated by a Protein Kinase C-dependent Mechanism
J. Biol. Chem., February 17, 1995; 270(7): 3346 - 3352.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1994 by the American Society for Pharmacology and Experimental Therapeutics